U.S. Markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
33.77-0.27 (-0.79%)
At close: 4:00PM EDT

33.88 0.11 (0.33%)
After hours: 7:59PM EDT

People also watch
Full screen
Previous Close34.04
Bid33.88 x 100
Ask33.93 x 200
Day's Range33.75 - 34.13
52 Week Range29.83 - 37.39
Avg. Volume21,532,439
Market Cap201.53B
PE Ratio (TTM)28.43
Earnings DateN/A
Dividend & Yield1.28 (3.75%)
Ex-Dividend Date2017-05-10
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com4 hours ago

    [$$] Merck Cholesterol Drug Could Help Unlock Value

    In the last decade, no fewer than three major pharmaceutical companies have suffered defeat trying to bring a new class of cholesterol-lowering medication to market.s Much to the surprise of investors, Merck & Co. (MRK) could succeed where Pfizer (PFE), Roche (RHHBY) and Eli Lilly & Co. (LLY) have all failed. Merck has yet to decide if it will seek Food and Drug Administration approval, a sign to some that the company isn’t sure if the study data, though positive, are strong enough to ensure regulatory approval. Thanks to the growing success of Merck’s immunotherapy cancer drug Keytruda, the shares have gained 19% in the past year to near a 52-week high of $66.80.

  • Market Realist10 hours ago

    A Look at Pfizer’s Revenue for 1Q17

    Pfizer (PFE) reported a 2.0% fall in 1Q17 revenues to ~$12.8 billion, with a 1.0% operational fall in revenues and a 1.0% negative impact of foreign exchange.

  • Market Realist11 hours ago

    Pfizer’s Valuation as of June 22, 2017

    Pfizer was trading at a forward PE multiple of ~12.8x on June 22, 2017, compared to the industry average of ~16.6x.